BioLine Rx Ltd (BLRX)
0.6419
+0.02
(+4.04%)
USD |
NASDAQ |
May 16, 16:00
0.642
0.00 (0.00%)
After-Hours: 20:00
BioLine Rx Enterprise Value: 18.09M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 18.09M |
| May 15, 2024 | 16.10M |
| May 14, 2024 | 18.33M |
| May 13, 2024 | 16.50M |
| May 10, 2024 | 18.90M |
| May 09, 2024 | 21.55M |
| May 08, 2024 | 19.52M |
| May 07, 2024 | 21.35M |
| May 06, 2024 | 24.20M |
| May 03, 2024 | 21.14M |
| May 02, 2024 | 19.55M |
| May 01, 2024 | 20.51M |
| April 30, 2024 | 20.29M |
| April 29, 2024 | 17.94M |
| April 26, 2024 | 15.67M |
| April 25, 2024 | 12.77M |
| April 24, 2024 | 15.78M |
| April 23, 2024 | 17.68M |
| April 22, 2024 | 20.91M |
| April 19, 2024 | 19.26M |
| April 18, 2024 | 17.95M |
| April 17, 2024 | 16.45M |
| April 16, 2024 | 17.89M |
| April 15, 2024 | 17.95M |
| April 12, 2024 | 24.08M |
| Date | Value |
|---|---|
| April 11, 2024 | 22.74M |
| April 10, 2024 | 25.59M |
| April 09, 2024 | 23.34M |
| April 08, 2024 | 27.65M |
| April 05, 2024 | 31.59M |
| April 04, 2024 | 32.61M |
| April 03, 2024 | 32.97M |
| April 02, 2024 | 33.08M |
| April 01, 2024 | 35.54M |
| March 28, 2024 | 47.91M |
| March 27, 2024 | 47.19M |
| March 26, 2024 | 41.39M |
| March 25, 2024 | 60.95M |
| March 22, 2024 | 66.75M |
| March 21, 2024 | 53.71M |
| March 20, 2024 | 52.98M |
| March 19, 2024 | 52.26M |
| March 18, 2024 | 50.08M |
| March 15, 2024 | 50.08M |
| March 14, 2024 | 52.26M |
| March 13, 2024 | 51.53M |
| March 12, 2024 | 50.08M |
| March 11, 2024 | 49.36M |
| March 08, 2024 | 52.26M |
| March 07, 2024 | 56.36M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-13.27M
Minimum
Dec 27 2022
157.02M
Maximum
May 04 2021
38.94M
Average
26.33M
Median
Aug 05 2020
Enterprise Value Benchmarks
| Compugen Ltd | 140.91M |
| Pluri Inc | 34.05M |
| XTL Biopharmaceuticals Ltd | 12.10M |
| Can Fite Biofarma Ltd | 2.244M |
| BiomX Inc | 14.51M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.88M |
| Revenue (Quarterly) | 4.80M |
| Total Expenses (Quarterly) | 16.66M |
| EPS Diluted (Quarterly) | -0.15 |
| Profit Margin (Quarterly) | -289.2% |
| Earnings Yield | -140.2% |